Review



custom probe against creert2  (Addgene inc)


Bioz Verified Symbol Addgene inc is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    Addgene inc custom probe against creert2
    Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult <t>Cx40-CreERT2</t> mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to <xref ref-type=Figures S1 and and Table S1 . " width="250" height="auto" />
    Custom Probe Against Creert2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 93 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom probe against creert2/product/Addgene inc
    Average 95 stars, based on 93 article reviews
    custom probe against creert2 - by Bioz Stars, 2026-04
    95/100 stars

    Images

    1) Product Images from "Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells"

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

    Journal: Developmental Cell

    doi: 10.1016/j.devcel.2024.03.003

    Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to <xref ref-type=Figures S1 and and Table S1 . " title="... Z )-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with ( Z )-4OHT. ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to Figures S1 and and Table S1 .

    Techniques Used: In Vivo, Mass Spectrometry, Clinical Proteomics, Injection, In Situ, Staining, Hybridization, Immunostaining, Flow Cytometry, Derivative Assay, Labeling

    Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to <xref ref-type=Figure S3 . " title="... functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to Figure S3 .

    Techniques Used: Derivative Assay, Functional Assay, In Vivo, Flow Cytometry

    Artery-derived HSCs are functional in vivo upon transplantation (A and B) Arteries were lineage-traced by administering 4OHT to E8.5 Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos. B6, C57BL/6 mouse. (C and D) ZsGreen+ E16.5 fetal liver HSCs were (B) analyzed by flow cytometry and (C and D) transplanted into lethally irradiated primary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (C) peripheral blood cells and (D) bone marrow HSCs in primary recipients. (E and F) Bone marrow from primary recipient mice was transplanted into lethally irradiated secondary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (E) peripheral blood and (F) bone marrow HSCs in secondary recipients. Data depict the mean ± SEM. Each dot represents a single mouse. Related to <xref ref-type=Figure S4 . " title="... Arteries were lineage-traced by administering 4OHT to E8.5 Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos. B6, C57BL/6 ..." property="contentUrl" width="100%" height="100%"/>
    Figure Legend Snippet: Artery-derived HSCs are functional in vivo upon transplantation (A and B) Arteries were lineage-traced by administering 4OHT to E8.5 Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos. B6, C57BL/6 mouse. (C and D) ZsGreen+ E16.5 fetal liver HSCs were (B) analyzed by flow cytometry and (C and D) transplanted into lethally irradiated primary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (C) peripheral blood cells and (D) bone marrow HSCs in primary recipients. (E and F) Bone marrow from primary recipient mice was transplanted into lethally irradiated secondary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (E) peripheral blood and (F) bone marrow HSCs in secondary recipients. Data depict the mean ± SEM. Each dot represents a single mouse. Related to Figure S4 .

    Techniques Used: Derivative Assay, Functional Assay, In Vivo, Transplantation Assay, Flow Cytometry, Irradiation


    Figure Legend Snippet:

    Techniques Used: Flow Cytometry, Blocking Assay, Immunostaining, Recombinant, Knock-Out, Membrane, In Vitro, Staining, Mass Spectrometry, Molecular Weight, Reverse Transcription, SYBR Green Assay, Library Quantification, Sample Prep, Isolation, Sequencing, Software



    Similar Products

    custom probe against creert2  (Addgene inc)
    95
    Addgene inc custom probe against creert2
    Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult <t>Cx40-CreERT2</t> mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to <xref ref-type=Figures S1 and and Table S1 . " width="250" height="auto" />
    Custom Probe Against Creert2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/custom probe against creert2/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    custom probe against creert2 - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier
    amplifier b1 molecular instruments custom probe against creert2  (Addgene inc)
    95
    Addgene inc amplifier b1 molecular instruments custom probe against creert2
    Figure 1. Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of (Z)-4OHT levels in plasma of female adult <t>Cx40-CreERT2</t> mice that intraperitoneally injected with (Z)-4OHT.
    Amplifier B1 Molecular Instruments Custom Probe Against Creert2, supplied by Addgene inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/amplifier b1 molecular instruments custom probe against creert2/product/Addgene inc
    Average 95 stars, based on 1 article reviews
    amplifier b1 molecular instruments custom probe against creert2 - by Bioz Stars, 2026-04
    95/100 stars
    		  Buy from Supplier

    Image Search Results


    Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to <xref ref-type=Figures S1 and and Table S1 . " width="100%" height="100%">

    Journal: Developmental Cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet: Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of ( Z )-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with ( Z )-4OHT. (C) Cx40 and CreERT2 in situ staining of E8.5 Cx40-CreERT2 mouse embryos, using hybridization chain reaction v3.0 (HCR3). Arrows: paired dorsal aortae. Ant, anterior; post, posterior. (D) scRNA-seq of the entire E8.5 mouse embryo. (E–J) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. The Cx40-CreERT2 allele also encodes RFP , which was used to visualize Cx40+ cells. (E, G, and I) Immunostaining and (F, H, and J) flow cytometry of E11.5 dorsal aorta, E11.5 yolk sac, and E16.5 fetal liver was performed. (K) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering a single 4OHT dose at the indicated times (E7.5–E12.5). Flow cytometry was performed to quantify artery-derived (i.e., ZsGreen+) HSCs in the E14.5–E18.5 fetal liver. Each dot: independent litter. For each time point, ≥8 independent embryos were analyzed. Inset: fetal liver HSCs labeled after E9.0 4OHT administration. (L) Arteries were lineage-traced in Efnb2-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E8.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. (M) Veins and capillaries were lineage-traced in Apj-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at E9.5. Flow cytometry was performed to quantify ZsGreen+ E14.5–E18.5 fetal liver HSCs. Histograms depict the mean ± standard error of the mean (SEM). ∗ p < 0.05, ∗∗ p < 0.01. Scale bars, 50 μm. Related to Figures S1 and and Table S1 .

    Article Snippet: HCR3 probe for CreERT2 , compatible with amplifier B1 , Molecular Instruments , Custom probe against CreERT2 (sequence deposited at https://www.addgene.org/14797/ ).

    Techniques: In Vivo, Mass Spectrometry, Clinical Proteomics, Injection, In Situ, Staining, Hybridization, Immunostaining, Flow Cytometry, Derivative Assay, Labeling

    Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to <xref ref-type=Figure S3 . " width="100%" height="100%">

    Journal: Developmental Cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet: Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to Figure S3 .

    Article Snippet: HCR3 probe for CreERT2 , compatible with amplifier B1 , Molecular Instruments , Custom probe against CreERT2 (sequence deposited at https://www.addgene.org/14797/ ).

    Techniques: Derivative Assay, Functional Assay, In Vivo, Flow Cytometry

    Artery-derived HSCs are functional in vivo upon transplantation (A and B) Arteries were lineage-traced by administering 4OHT to E8.5 Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos. B6, C57BL/6 mouse. (C and D) ZsGreen+ E16.5 fetal liver HSCs were (B) analyzed by flow cytometry and (C and D) transplanted into lethally irradiated primary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (C) peripheral blood cells and (D) bone marrow HSCs in primary recipients. (E and F) Bone marrow from primary recipient mice was transplanted into lethally irradiated secondary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (E) peripheral blood and (F) bone marrow HSCs in secondary recipients. Data depict the mean ± SEM. Each dot represents a single mouse. Related to <xref ref-type=Figure S4 . " width="100%" height="100%">

    Journal: Developmental Cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet: Artery-derived HSCs are functional in vivo upon transplantation (A and B) Arteries were lineage-traced by administering 4OHT to E8.5 Cx40-CreERT2 ; Ai6 ( ZsGreen reporter) embryos. B6, C57BL/6 mouse. (C and D) ZsGreen+ E16.5 fetal liver HSCs were (B) analyzed by flow cytometry and (C and D) transplanted into lethally irradiated primary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (C) peripheral blood cells and (D) bone marrow HSCs in primary recipients. (E and F) Bone marrow from primary recipient mice was transplanted into lethally irradiated secondary recipient mice. 1–4 months post transplantation, flow cytometry was performed to quantify ZsGreen+ (E) peripheral blood and (F) bone marrow HSCs in secondary recipients. Data depict the mean ± SEM. Each dot represents a single mouse. Related to Figure S4 .

    Article Snippet: HCR3 probe for CreERT2 , compatible with amplifier B1 , Molecular Instruments , Custom probe against CreERT2 (sequence deposited at https://www.addgene.org/14797/ ).

    Techniques: Derivative Assay, Functional Assay, In Vivo, Transplantation Assay, Flow Cytometry, Irradiation

    Journal: Developmental Cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet:

    Article Snippet: HCR3 probe for CreERT2 , compatible with amplifier B1 , Molecular Instruments , Custom probe against CreERT2 (sequence deposited at https://www.addgene.org/14797/ ).

    Techniques: Flow Cytometry, Blocking Assay, Immunostaining, Recombinant, Knock-Out, Membrane, In Vitro, Staining, Mass Spectrometry, Molecular Weight, Reverse Transcription, SYBR Green Assay, Library Quantification, Sample Prep, Isolation, Sequencing, Software

    Figure 1. Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of (Z)-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with (Z)-4OHT.

    Journal: Developmental cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells.

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet: Figure 1. Genetic lineage tracing reveals that artery endothelial cells generate HSCs in vivo (A) Experimental strategy. DA, dorsal aorta; FL, fetal liver; PB, peripheral blood; BM, bone marrow; E, embryonic day; P, postnatal day. (B) Mass spectrometry quantification of (Z)-4OHT levels in plasma of female adult Cx40-CreERT2 mice that intraperitoneally injected with (Z)-4OHT.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER H7 CAG-AkaLuc-PuroR hESCs Kyle Loh’s laboratory (Stanford University) This study WTC11 hiPSCs Coriell Institute for Medical Research Coriell Institute for Medical Research, GM25256, Kreitzer et al.148 OP9-DLL4-IRES-GFP feeder cells Juan Carlos Zúñiga-Pfl€ucker’s laboratory (University of Toronto) Mohtashami et al.149 MS5 feeder cells DSMZ ACC 441 Human cord blood CD34+ hematopoietic stem and progenitor cells (pooled from mixed donors) StemExpress CB3400.5C Experimental models: organisms/strains Mus musculus (mouse): Cx40-CreERT2 Lucile Miquerol’s laboratory (Aix-Marseille Université) Beyer et al.77 Mus musculus (mouse): Efnb2-CreERT2 Kyle Loh’s laboratory (Stanford University) This study (being deposited at The Jackson Laboratory [JAX], 038831) Mus musculus (mouse): Apj-CreERT2 Kristy Red-Horse’s laboratory (Stanford University) Chen et al.91 Mus musculus (mouse): Rosa26-CAG-LoxP-StopLoxP-ZsGreen (Ai6) The Jackson Laboratory JAX 007906 (Madisen et al.78) Mus musculus (mouse): FVB/NJ The Jackson Laboratory JAX 001800 Mus musculus (mouse): C57BL/6-CD45.2 The Jackson Laboratory JAX 000664 Mus musculus (mouse): C57BL/6-CD45.1 (Pepboy) The Jackson Laboratory JAX 002014 Mus musculus (mouse): NOD-SCID Il2rg-/- (NSG) The Jackson Laboratory JAX 005557 (Shultz et al.150) Oligonucleotides Primers See Table S4 N/A HCR3 probe for mouse Gja5 (Cx40), compatible with amplifier B3 Molecular Instruments Custom probe against Gja5 (sequence deposited at NCBI accession NM_001271628) HCR3 probe for CreERT2, compatible with amplifier B1 Molecular Instruments Custom probe against CreERT2 (sequence deposited at https:// www.addgene.org/14797/) HCR3 B3-Alexa Fluor 647 amplifier probe Molecular Instruments B3-Alexa Fluor 647 HCR3 B1-Alexa Fluor 488 amplifier probe Molecular Instruments B1-Alexa Fluor 488 Software and algorithms anndata Fabian Theis’s laboratory (Helmholtz Munich) https://github.com/ theislab/anndata AnnotationDbi Hervé Pagès, Marc Carlson, Seth Falcon, Nianhua Li (Bioconductor Team) https://github.com/ Bioconductor/ AnnotationDbi biomaRt Damian Smedley, Syed Haider, Benoit Ballester, Richard Holland, Darin London, Gudmundur Thorisson, Arek Kasprzyk (Bioconductor Team) https://github.com/ grimbough/biomaRt CellRanger 10x Genomics https://support.

    Techniques: In Vivo, Mass Spectrometry, Clinical Proteomics, Injection

    Figure 2. Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2; Ai6 (ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to Figure S3.

    Journal: Developmental cell

    Article Title: Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells.

    doi: 10.1016/j.devcel.2024.03.003

    Figure Lengend Snippet: Figure 2. Artery-derived HSCs are functional in vivo (A–E) Arteries were lineage-traced in Cx40-CreERT2; Ai6 (ZsGreen reporter) embryos by administering 4OHT at either E8.0, E8.5, or E9.0. After embryos developed into adults, flow cytometry was performed to quantify ZsGreen+ cells in (B) and (C) peripheral blood and (C) and (D) bone marrow HSCs in 1- to 22-month-old adult mice. Line graphs depict the mean ± SEM. Related to Figure S3.

    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER H7 CAG-AkaLuc-PuroR hESCs Kyle Loh’s laboratory (Stanford University) This study WTC11 hiPSCs Coriell Institute for Medical Research Coriell Institute for Medical Research, GM25256, Kreitzer et al.148 OP9-DLL4-IRES-GFP feeder cells Juan Carlos Zúñiga-Pfl€ucker’s laboratory (University of Toronto) Mohtashami et al.149 MS5 feeder cells DSMZ ACC 441 Human cord blood CD34+ hematopoietic stem and progenitor cells (pooled from mixed donors) StemExpress CB3400.5C Experimental models: organisms/strains Mus musculus (mouse): Cx40-CreERT2 Lucile Miquerol’s laboratory (Aix-Marseille Université) Beyer et al.77 Mus musculus (mouse): Efnb2-CreERT2 Kyle Loh’s laboratory (Stanford University) This study (being deposited at The Jackson Laboratory [JAX], 038831) Mus musculus (mouse): Apj-CreERT2 Kristy Red-Horse’s laboratory (Stanford University) Chen et al.91 Mus musculus (mouse): Rosa26-CAG-LoxP-StopLoxP-ZsGreen (Ai6) The Jackson Laboratory JAX 007906 (Madisen et al.78) Mus musculus (mouse): FVB/NJ The Jackson Laboratory JAX 001800 Mus musculus (mouse): C57BL/6-CD45.2 The Jackson Laboratory JAX 000664 Mus musculus (mouse): C57BL/6-CD45.1 (Pepboy) The Jackson Laboratory JAX 002014 Mus musculus (mouse): NOD-SCID Il2rg-/- (NSG) The Jackson Laboratory JAX 005557 (Shultz et al.150) Oligonucleotides Primers See Table S4 N/A HCR3 probe for mouse Gja5 (Cx40), compatible with amplifier B3 Molecular Instruments Custom probe against Gja5 (sequence deposited at NCBI accession NM_001271628) HCR3 probe for CreERT2, compatible with amplifier B1 Molecular Instruments Custom probe against CreERT2 (sequence deposited at https:// www.addgene.org/14797/) HCR3 B3-Alexa Fluor 647 amplifier probe Molecular Instruments B3-Alexa Fluor 647 HCR3 B1-Alexa Fluor 488 amplifier probe Molecular Instruments B1-Alexa Fluor 488 Software and algorithms anndata Fabian Theis’s laboratory (Helmholtz Munich) https://github.com/ theislab/anndata AnnotationDbi Hervé Pagès, Marc Carlson, Seth Falcon, Nianhua Li (Bioconductor Team) https://github.com/ Bioconductor/ AnnotationDbi biomaRt Damian Smedley, Syed Haider, Benoit Ballester, Richard Holland, Darin London, Gudmundur Thorisson, Arek Kasprzyk (Bioconductor Team) https://github.com/ grimbough/biomaRt CellRanger 10x Genomics https://support.

    Techniques: Derivative Assay, Functional Assay, In Vivo, Cytometry